Literature DB >> 18385119

Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy.

Ingegerd Ostman-Smith1, Göran Wettrell, Barry Keeton, Daniel Holmgren, Ulf Ergander, Steven Gould, Colene Bowker, Mario Verdicchio.   

Abstract

AIMS: Hypertrophic cardiomyopathy (HCM) is the commonest inherited cause of sudden cardiac death in children; current guidelines suggest HCM screening after 12-15 years of age. The study aims to establish the age range at highest risk. METHODS AND
RESULTS: Cohort study from six regional centres of paediatric cardiology, including children presenting with sudden death; n = 150 (59% = male; 39% familial HCM). Age- and gender-specific mortality was calculated, and compared with rates calculated from the Swedish National Cause of Death Registry. There were 56 deaths within the cohort, 39 were sudden arrhythmia deaths, with 31 at <19 years of age. Between 9-13.9 years of age annual sudden death mortality averages 7.2%, vs. 1.7% after 16 years of age; P = 0.025, odds ratio for proportions 3.75 [95% confidence intervals (CI) 1.18-11.91], similar in both familial and idiopathic HCM. The risk for sudden death peaks earlier in girls (10-11 years), with male preponderance after the age of 15. National cause of death statistics confirm that the mortality rate from HCM is significantly higher in the 8-16 year olds (0.112 per 100,000 age-specific population) than in the 17-30 year olds (0.055 per 100,000; 95% CI 0.011-0.099).
CONCLUSION: In families with HCM, children should be screened at an early age.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385119     DOI: 10.1093/eurheartj/ehn122

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

1.  Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death.

Authors:  Brett R Anderson; Sean McElligott; Daniel Polsky; Victoria L Vetter
Journal:  Pediatr Cardiol       Date:  2013-09-05       Impact factor: 1.655

2.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

Review 3.  Hypertrophic cardiomyopathy: genetics and clinical perspectives.

Authors:  Cordula Maria Wolf
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

4.  Genetic background of Japanese patients with pediatric hypertrophic and restrictive cardiomyopathy.

Authors:  Takeharu Hayashi; Kousuke Tanimoto; Kayoko Hirayama-Yamada; Etsuko Tsuda; Mamoru Ayusawa; Shinichi Nunoda; Akira Hosaki; Akinori Kimura
Journal:  J Hum Genet       Date:  2018-06-15       Impact factor: 3.172

5.  Pre-symptomatic genetic testing for inherited cardiac conditions: a qualitative exploration of psychosocial and ethical implications.

Authors:  Elizabeth Ormondroyd; Stephanie Oates; Michael Parker; Edward Blair; Hugh Watkins
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

6.  Beta-Blockers in Pediatric Hypertrophic Cardiomyopathies.

Authors:  Ingegerd Östman-Smith
Journal:  Rev Recent Clin Trials       Date:  2014

7.  Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events.

Authors:  Niccolò Maurizi; Silvia Passantino; Gaia Spaziani; Francesca Girolami; Anna Arretini; Mattia Targetti; Iva Pollini; Alessia Tomberli; Silvia Pradella; Giovanni Battista Calabri; Veronica Vinattieri; Bruno Bertaccini; Ornella Leone; Luciano De Simone; Claudio Rapezzi; Niccolò Marchionni; Franco Cecchi; Silvia Favilli; Iacopo Olivotto
Journal:  JAMA Cardiol       Date:  2018-06-01       Impact factor: 14.676

8.  Long-term outcomes of childhood onset Noonan compared to sarcomere hypertrophic cardiomyopathy.

Authors:  Emanuel Kaltenecker; Julia Schleihauf; Christian Meierhofer; Nerejda Shehu; Naira Mkrtchyan; Alfred Hager; Andreas Kühn; Julie Cleuziou; Karin Klingel; Heide Seidel; Martin Zenker; Peter Ewert; Gabriele Hessling; Cordula M Wolf
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

9.  Sudden cardiac death in young athletes; a literature review and special considerations in Asia.

Authors:  Farzin Halabchi; Tohid Seif-Barghi; Reza Mazaheri
Journal:  Asian J Sports Med       Date:  2011-03

Review 10.  Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere.

Authors:  Gabrielle Norrish; Ella Field; Juan P Kaski
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.